Avoro Capital Advisors LLC Autolus Therapeutics PLC Put Options Transaction History
Avoro Capital Advisors LLC
- $6.86 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AUTL
# of Institutions
114Shares Held
166MCall Options Held
2.8KPut Options Held
13.4K-
Wellington Management Group LLP Boston, MA25.3MShares$49.2 Million0.01% of portfolio
-
Blackstone Inc New York, NY20.5MShares$39.7 Million0.35% of portfolio
-
Syncona Portfolio LTD Guernsey, Channel Islands, X016.6MShares$32.3 Million73.83% of portfolio
-
Deep Track Capital, LP Greenwich, CT14.2MShares$27.6 Million1.47% of portfolio
-
Tfg Asset Management Gp LTD Grand Cayman, E98MShares$15.5 Million10.85% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $176M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...